Total planned funding: $2,917,156,762
Clear active filters
Treatment
HTXD: Treatment: ARV Drugs
Private Contractor
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Allocations
Countries/Regions
Nigeria | $698,160,392 |
Zambia | $450,740,471 |
Tanzania | $367,892,582 |
Mozambique | $257,786,778 |
Uganda | $184,385,539 |
Côte d'Ivoire | $161,334,011 |
Zimbabwe | $140,127,497 |
Rwanda | $111,866,767 |
Kenya | $100,797,518 |
Ethiopia | $89,880,104 |
Haiti | $87,243,805 |
Democratic Republic of the Congo | $73,204,430 |
Vietnam | $66,776,562 |
South Africa | $30,414,366 |
Eswatini | $21,237,938 |
Cameroon | $15,792,109 |
Ukraine | $11,405,290 |
Guyana | $8,412,752 |
Namibia | $7,246,313 |
Malawi | $6,995,287 |
Burundi | $6,152,614 |
West Africa Region | $5,572,690 |
Botswana | $4,760,410 |
Western Hemisphere Region | $4,559,082 |
South Sudan | $2,970,498 |
Asia Regional Program | $600,500 |
Lesotho | $482,041 |
enumerations.Philippines | $358,416 |
Organizational Types
Private Contractor | $2,917,156,762 |
Program Areas
Treatment | $2,917,156,762 |
Budget Codes
HTXD: Treatment: ARV Drugs | $2,917,156,762 |
Top Partner Programs
Chemonics International:
$1,456,653,768
View countries
Partnership for Supply Chain Management:
$1,437,728,908
View countries
John Snow, Inc:
$9,790,000
View countries